Patents Assigned to ASCENSIA DIABETES CARE HOLDING AG
  • Patent number: 11963763
    Abstract: A continuous glucose monitoring (CGM) device may include a wearable portion having a sensor configured to produce glucose signals from interstitial fluid, a processor, a memory and transmitter circuitry. The memory may include a pre-determined gain function based on a point-of-interest glucose signal and glucose signals measured prior to the point-of-interest glucose signal. The memory may also include computer program code stored therein that, when executed by the processor, causes the CGM device to (a) measure and store a plurality of glucose signals using the sensor and memory; (b) for a presently-measured glucose signal, employ the plurality of previously-measured glucose signals stored in the memory and the pre-determined gain function to compute a compensated glucose value; and (c) communicate the compensated glucose value to a user of the CGM device. Numerous other embodiments are provided.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: April 23, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Huan-Ping Wu
  • Patent number: 11950904
    Abstract: A method of determining glucose values during continuous glucose monitoring (CGM) measurements includes providing a CGM device including a sensor, a memory, and a processor; applying a constant voltage potential to the sensor; measuring a primary current signal resulting from the constant voltage potential and storing the measured primary current signal in the memory; applying a probing potential modulation sequence to the sensor; measuring probing potential modulation current signals resulting from the probing potential modulation sequence and storing measured probing potential modulation current signals in the memory; determining an initial glucose concentration based on a conversion function and a measured probing potential modulation current signal; determining a connection function value based on the primary current signal and a plurality of the probing potential modulation current signals; and determining a final glucose concentration based on the initial glucose concentration and the connection functio
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: April 9, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Mark D. Cerutti
  • Patent number: 11930435
    Abstract: Some embodiments of the present invention include pairing two wireless devices by placing at least one of two devices in a pairing mode; performing at least one pairing motion event with at least one of the wireless devices to satisfy at least one pairing condition; detecting satisfaction of the at least one pairing condition; and pairing the two wireless devices in response to detecting satisfaction of the at least one pairing condition. Numerous other aspects are provided.
    Type: Grant
    Filed: July 22, 2022
    Date of Patent: March 12, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Qiang Fu, Alexander Markovic, Joseph R. Anstett, Jr., Vladislav Milenkovic
  • Patent number: 11913898
    Abstract: During analyte analysis, errors may be introduced into an analysis by both the biosensor system used to perform the analysis and by errors in the output signal measured by the measurement device of the biosensor. For a reference sample, system error may be determined through the determination of relative error. However, during an analysis of a test sample with the measurement device of the biosensor system, true relative error cannot be known. A pseudo-reference concentration determined during the analysis may be used as a substitute for true relative error. The present invention introduces the determination of a pseudo-reference concentration determined during the analysis as a substitute for the true relative error and uses an anchor parameter to compensate for the system error in the analysis-determined pseudo-reference concentration.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: February 27, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Huan-Ping Wu
  • Patent number: 11911073
    Abstract: A biosensor inserter includes a push member with a push element, a contact member including a latch, a transmitter carrier supporting a transmitter and sensor assembly, and a pivot member having a latch end, the pivot member supporting an insertion device during biosensor insertion. In operation, the push member is telescoped axially by the user relative to the contact member, which is provided in contact with a user's skin. This pushes the push element against the pivot member and translates the transmitter carrier during insertion of the biosensor. During a first portion of a stroke of the insertion device, insertion of the biosensor is accomplished, and the pivot member is prevented from pivoting. In a second portion of the stroke, after latch end moves past the latch, the pivot member is allowed to pivot and the insertion device is retracted. Other system and method embodiments are provided.
    Type: Grant
    Filed: February 8, 2023
    Date of Patent: February 27, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Nicholas Erekovcanski, Eugene R. Prais, Thomas A. J. Mayer, Jr., Cameron M. Young
  • Patent number: 11910531
    Abstract: A flexible printed circuit board (PCB) may have one or more coin cell batteries mounted thereto such that the flexibility of the flexible PCB is maintained. The flexible PCB has one or more battery contact pads fabricated thereon. Each battery contact pad includes a pattern of metalized vias each extending from a top surface to a bottom surface of the flexible PCB. A coin cell battery may be positioned over or under the battery contact pad. Conductive light curable epoxy is applied to and in each metalized via to contact and adhere to the coin cell battery to form a conductive path from the battery through the battery contact pad to printed conductors on the flexible PCB. Methods of mounting one or more coin cell batteries to a flexible PCB are also provided, as are other aspects.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: February 20, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Igor Y. Gofman
  • Patent number: 11872035
    Abstract: A method of determining glucose values during continuous glucose monitoring (CGM) measurements includes providing a CGM device including a sensor, a memory, and a processor; applying a constant voltage potential to the sensor; measuring a primary current signal resulting from the constant voltage potential and storing the measured primary current signal in the memory; applying a probing potential modulation sequence to the sensor; measuring probing potential modulation current signals resulting from the probing potential modulation sequence and storing measured probing potential modulation current signals in the memory; determining an initial glucose concentration based on a conversion function value and the primary current signal; determining a connection function based on the primary current signal and a plurality of the probing potential modulation current signals; and determining a final glucose concentration based on the initial glucose concentration and the connection function value.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: January 16, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Mark D. Cerutti
  • Patent number: 11864924
    Abstract: A method of filtering a signal in a continuous analyte monitoring (CAM) system includes applying time-varying filtering to the signal using a time-varying filter to generate a filtered continuous analyte monitoring signal during an analyte monitoring period. Other methods, apparatus, continuous analyte monitoring devices, and continuous glucose monitoring devices are also disclosed.
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: January 9, 2024
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Anthony P. Russo
  • Patent number: 11839406
    Abstract: A biosensor inserter is configured to insert a biosensor. The biosensor inserter includes a push member including a receiver, a contact member translatable relative to the push member, and a trocar holder having a sheath configured to receive a trocar assembly including a trocar therein. The trocar holder is configured to be insertable into, and removable from, the receiver. Thus, an amount of medical waste can be minimized by discarding only the removable trocar holder and trocar assembly after use. System and method embodiments are provided.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: December 12, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Dragan Avirovikj, Jon Taylor, John Longan, Chris Labak
  • Patent number: 11837339
    Abstract: A portable data-management system based on an analyte testing device which communicates wirelessly with a mobile device. The mobile device runs an application to manage and analyze data obtained by the analyte testing device. The mobile device may assist the user in displaying testing data, identifying patterns to assist healthy behavior or issue warnings based on the collected data. The mobile device may be connected to a network to store user health data for use by other parties.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: December 5, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jun Chen, Harris Lieber, Erik Nelson, Jeffery S. Reynolds, Kevin Curran, Aseem Mehta, Dawn Rountree
  • Patent number: 11806134
    Abstract: In some embodiments, a sensor assembly for a continuous glucose monitoring system is provided that includes (1) a sensor carrier having a sensor unit receiving area and an electronics receiving area, the electronics receiving area including a substrate; (2) a sensor unit having a sterilized region, the sterilized region including at least a portion of a sensor and an introducer; and (3) electronics for the continuous glucose monitoring system. The sensor unit is positioned within the sensor unit receiving area of the sensor carrier and the electronics are positioned on the substrate within the electronics receiving area of the sensor carrier so as to form a sensor assembly having the sensor electrically connected to the substrate of the electronics receiving area while maintaining sterilization of the sterilized region of the sensor unit. Numerous other aspects are provided.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: November 7, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Eugene Prais, Jennifer L. Gass, Nihir Patel, Nikhil M. Shah
  • Patent number: 11808756
    Abstract: Sensor clip assemblies, sensor clips, analyte testing systems, and methods for making and using the same are disclosed. A sensor clip assembly is disclosed for storing and dispensing analyte testing sensors. The sensor clip assembly includes numerous test sensors arranged in a stack. Each test sensor is configured to assist in testing an analyte in a fluid sample. The sensor clip assembly also includes a skeletal frame with a top, a bottom, and numerous sides. The top, bottom and sides are interconnected to define an internal chamber within which is stored the stack of test sensors. At least one of the sides includes one or more elongated rails with structural gaps on opposing sides thereof. For some configurations, multiple sides of the skeletal frame comprise at least one or multiple elongated rails, each of which has structural gaps on opposing sides thereof and may be columnar in nature.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: November 7, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jeffery S. Reynolds, Eugene R. Prais
  • Patent number: 11812551
    Abstract: A flexible circuit board for a continuous analyte monitoring (CAM) device includes a plurality of physically separate circuit board cells each having circuitry thereon. The flexible circuit board also includes a plurality of flexible interconnections each connecting one of the physically separate circuit board cells to another of the physically separate circuit board cells. Each one of the flexible interconnections is operable to couple power, electrical signals, or both to the physically separate circuit board cells connected thereto. The flexible circuit board is bendable in multiple directions in three dimensions. Methods of constructing flexible circuit boards for CAM devices are also provided, as are other aspects.
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: November 7, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Ji Li, Igor Y. Gofman, Dragan Avirovikj, Thomas A. J. Mayer, Jr., Cameron M. Young, Nicholas Erekovcanski
  • Patent number: 11803534
    Abstract: Embodiments provide systems, methods, and apparatus for reducing the impact of user-entered data errors in a data management system (DMS) such as for diabetes. Embodiments include storing user-entered data received from a user into a primary DMS database; storing secondary data received from a source other than the user into a secondary tracking database; associating the secondary data with one or more events described by the user-entered data; cross-checking the user-entered data against the associated secondary data; evaluating user-entered data based on the cross-checking results; presenting for review evaluated user-entered data; treating user-entered data in the primary DMS database based on review results; and determining a diabetes management plan based on the treated user-entered data. Numerous other aspects are provided.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: October 31, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Kevin Curran
  • Patent number: 11751778
    Abstract: A sensor apparatus for a continuous glucose monitoring system has a sensor housing that includes a first end having a sealing surface configured to seal against an introducer having an insertion shaft, a second end having a sealing surface configured to seal against an insertion shaft cover, and an insertion shaft opening having a width that allows the insertion shaft to travel there through and that extends between the first and second ends. The sensor housing may further include a sensor wire channel that extends between the insertion shaft opening and a sensor wire contact location in an outer surface of the sensor housing. The sensor wire channel and sensor wire contact location may be configured to receive a sensor that extends between the insertion shaft opening and the sensor wire contact location to allow the sensor to make electrical contact to system circuitry. Numerous other aspects are provided.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: September 12, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Cameron M. Young, Jennifer L. Gass, Thomas A. J. Mayer, Jr., Eugene Prais
  • Patent number: 11737688
    Abstract: Apparatus and methods are operative to probe the condition of a sensor either initially, at any point thereafter or continuously during a continuous sensor operation for measuring an analyte in a bodily fluid (such as performed by, e.g., a continuous glucose monitoring (CGM) sensor). Results of the probe may include calibration indices determined from electrical signals obtained during the probe. The calibration indices may indicate whether in-situ adjustment of the sensor's calibration should be performed either initially and/or at random check points. Probing potential modulation parameters also may be used during analyte calculations to reduce the effects of lot-to-lot sensitivity variations, sensitivity drift during monitoring, temperature, interferents, and/or the like. Other aspects are disclosed.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: August 29, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Mark D. Cerutti
  • Patent number: 11723559
    Abstract: In some embodiments, a sensor assembly for a continuous glucose monitoring system is provided that includes (1) a sensor carrier having a sensor unit receiving area and an electronics receiving area, the electronics receiving area including a substrate; (2) a sensor unit having a sterilized region, the sterilized region including at least a portion of a sensor and an introducer; and (3) electronics for the continuous glucose monitoring system. The sensor unit is positioned within the sensor unit receiving area of the sensor carrier and the electronics are positioned on the substrate within the electronics receiving area of the sensor carrier so as to form a sensor assembly having the sensor electrically connected to the substrate of the electronics receiving area while maintaining sterilization of the sterilized region of the sensor unit. Numerous other aspects are provided.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: August 15, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Eugene Prais, Jennifer L. Gass, Nihir Patel, Nikhil M. Shah
  • Patent number: 11726054
    Abstract: An electrochemical test sensor is adapted to receive a fluid sample including an analyte. The electrochemical test sensor includes a base. The base includes an enzyme adapted to react with the analyte. The electrochemical test sensor further includes a plurality of electrodes, a near field communication (NFC) tag chip, an analog front end (AFE) and a microcontroller.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: August 15, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Anthony P. Russo
  • Patent number: 11707297
    Abstract: An inserter apparatus (e.g., a continuous analyte monitoring inserter apparatus) includes an outer member; an inner member; a transmitter carrier configured to support a transmitter and biosensor assembly during insertion of a biosensor, the transmitter carrier including a bias member; and a pivot member configured to pivot at times relative to the transmitter carrier and support an insertion device during biosensor insertion. The outer member is configured to press the bias member against the pivot member during insertion of the biosensor. During a first stroke portion of the insertion apparatus, the pivot member is prevented from pivoting. In a second stroke portion, pivoting is allowed, and the bias member causes, pivoting of the pivot member and retraction of the insertion device. Other systems and methods embodiments are provided.
    Type: Grant
    Filed: August 3, 2020
    Date of Patent: July 25, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jennifer L. Gass, Eugene R. Prais, Thomas A. J. Mayer, Jr., Cameron M. Young, Nicholas Erekovcanski
  • Patent number: 11678820
    Abstract: A continuous glucose monitoring (CGM) device may include a wearable portion having a sensor configured to produce glucose signals from interstitial fluid, a processor, a memory and transmitter circuitry. The memory may include a pre-determined gain function based on a point-of-interest glucose signal and glucose signals measured prior to the point-of-interest glucose signal. The memory may also include computer program code stored therein that, when executed by the processor, causes the CGM device to (a) measure and store a plurality of glucose signals using the sensor and memory; (b) for a presently-measured glucose signal, employ the plurality of previously-measured glucose signals stored in the memory and the pre-determined gain function to compute a compensated glucose value; and (c) communicate the compensated glucose value to a user of the CGM device. Numerous other embodiments are provided.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: June 20, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Huan-Ping Wu